Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial-Reference-Cited by-同舟云学术

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial

Published:2023-02 Issue: Volume:27 Page:100585
ISSN:2666-3546
Container-title:Brain, Behavior, & Immunity - Health
language:en
Short-container-title:Brain, Behavior, & Immunity - Health

Author:

Zwiep J.C.^ORCID,Bet P.M.,Rhebergen D.,Nurmohamed M.T.,Vinkers C.H.,Penninx B.W.J.H.,Milaneschi Y.,Lamers F.

Publisher

Elsevier BV

Subject

Nephrology

Reference40 articles.

1. Diagnostic and Statistical Manual of Mental Disorders,2013

2. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium;Arteaga-Henriquez;Front. Psychiatr.,2019

3. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: a 6-week double-blind placebo controlled randomized trial;Baune;Eur. Neuropsychopharmacol,2021

4. Fatigue among working people: validity of a questionnaire measure;Beurskens;Occup. Environ. Med.,2000

5. The list of threatening experiences - the reliability and validity of a brief life events questionnaire;Brugha;Acta Psychiatr. Scand.,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of immuno-metabolic depression features in the effects of light therapy in patients with depression and type 2 diabetes mellitus: A randomized controlled trial;Journal of Psychosomatic Research;2024-06

2. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials;The British Journal of Psychiatry;2023-12-22

3. Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients;Journal of Personalized Medicine;2023-09-20

4. Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorder;Journal of Neurochemistry;2023-08-27

5. Metabolomics signatures of depression: the role of symptom profiles;Translational Psychiatry;2023-06-10